Lessons from dog lifespan therapeutics for their human companions

Coverage, in order

1. 15d ago
   
   Rapamycin News obscure

   Lessons from dog lifespan therapeutics for their human companions

   Three executives from Loyal, a San Francisco company developing lifespan drugs for dogs, argue that human longevity medicine is blocked less by science than by regulation and economics. Their proposal has two parts. The first is to validate surrogate endpoints that respond quickly enough to…

Alivewire groups outlets reporting the same story. Each headline links to the outlet that wrote it; nothing is republished here.